TrialScope Transparency Named a Top Innovation for 2018

TrialScope’s Clinical Trial Transparency Service (CTTS) Named One of PM360’s
Most Innovative Healthcare Services of 2018

Company recognized for new solution, which provides dynamic, customizable
clinical trial websites for sponsors

Jersey City, NJ, Dec. 18, 2018 — TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has selected its Clinical Trial Transparency Service (CTTS) as one of the most innovative services of the year in the life sciences industry.

CTTS drives improved patient engagement, lower costs and increased transparency by enabling sponsors to engage with patients, healthcare professionals, researchers and the public via dedicated clinical trial informational websites. These websites — designed with mobile- and user-friendly design along with easily understandable content — are automatically updated with information provided to ClinicalTrials.gov.

“We are thrilled that our efforts to improve clinical trial transparency have been recognized by PM360,” said TrialScope CEO Jeff Kozloff. “This is a reflection of an overall trend in the pharmaceutical industry toward increased transparency, with an emphasis on health literacy and its impact on patient engagement. As CEO, my goal is to extend the vision of the TrialScope platform so that it becomes the one source of truth for validated clinical trial information.”

PM360 received hundreds of nominations from across the healthcare and life sciences industries in the categories of companies, startups, divisions, products, services and strategies. The PM360 editorial staff evaluated the submissions, and the most innovative — regardless of category — were selected.

“We hope this issue can serve as a must-have guide to help those working in this industry to find the offerings and partners that can take their work and company to the next level,” says Anna Stashower, CEO/Publisher of PM360. “The innovations featured in this issue represent some of the most exciting, new developments in life sciences that can help the industry in its mission to improve the lives of patients, ease the burden of physicians, work with payers to increase access to medication, and provide a better understanding of diseases and the treatments available.”

The picks are published in PM360’s 7th Annual Innovations Issue, which was established to provide a comprehensive overview of the latest advancements within healthcare and life sciences, and offers brief profiles of each compelling innovation selected. TrialScope's innovator profile can be found online at PM360.

For more information on TrialScope or its Clinical Trial Transparency Service, visit TrialScope.com.

About TrialScope

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit TrialScope.com.